Williams B S, Hinkle G H, Douthit R A, Fry J P, Pozderac R F, Olsen J O
Division of Nuclear Medicine and College of Pharmacy, The Ohio State University Medical Center, Columbus 43210, USA.
J Nucl Med Technol. 1999 Dec;27(4):309-17.
Identification of sentinel lymph nodes (SLNs) using lymphoscintigraphy, the blue dye technique and intraoperative lymphatic mapping with a gamma-detecting probe has become the standard of care in diagnosing and treating melanoma. Numerous clinical studies have proven the reliability of predicting the histology of remaining lymph nodes in the lymphatic basin from the histologic evaluation of the SLNs. Technical and clinical factors presented in this paper have been shown to increase the accuracy of localization of SLNs. The nuclear medicine technologist shares a vital role in the radiopharmaceutical preparation and administration for preoperative lymphoscintigraphy and intraoperative lymphatic mapping in patients with melanoma.
